Prevalence of Toxoplasma gondii among immunocompromised patients (heamodialysis and cancer) in the province of Thi-Qar-Iraq
The current study was conducted in Thi-Qar province to investigate of Toxoplasma gondii prevalence among renal dialysis and cancer patients by using anti-Toxoplasmosis IgG and IgM by ELISA also the study determined of some factors that may affected the prevalence of infection, such as age, sex,...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Thi-Qar
2019-04-01
|
| Series: | مجلة علوم ذي قار |
| Subjects: | |
| Online Access: | http://jsci.utq.edu.iq/index.php/main/article/view/41 |
| _version_ | 1797404192904577024 |
|---|---|
| author | Noor Kadhim Matar AL-Rekaby Bassad A.AL-Aboody |
| author_facet | Noor Kadhim Matar AL-Rekaby Bassad A.AL-Aboody |
| author_sort | Noor Kadhim Matar AL-Rekaby |
| collection | DOAJ |
| description | The current study was conducted in Thi-Qar province to investigate of Toxoplasma gondii prevalence among renal dialysis and cancer patients by using anti-Toxoplasmosis IgG and IgM by ELISA also the study determined of some factors that may affected the prevalence of infection, such as age, sex, marital status, place of residence and a number of chemical dosing that exposed to it cancer patient or the number of times the dialysis for renal dialysis patients.
The results of the current study showed that the prevalence of toxoplasmosis in Thi-Qar province in both renal dialysis and cancer patients and control group were 28% and 36% and 24% respectively. recorded results of Enzyme Linked Immunosorbent Assay ELISA test results for a positive antibody IgG in both renal dialysis and cancer patients and control group 25% , 30% , 22% respectively. As for the IgM antibody study did not record any positive result in both categories of the study (dialysis and cancer) only control group was 2%. The result of IgG & IgM together in renal dialysis and cancer and control group 3%, 6%, 0% respectively.
The study found that the increase in the number of times the dialysis increased incidence of infection prevalence it was 25.53% for patients who conducted the dialysis treatment more than six times and 16.66% for patients who have less than six times.For factor chemical dosing show high infection rates in patients who have been exposed to more than one dose of a chemical 37.63% As for those who were not exposed to any chemical dose was ratios have 14.29% . |
| first_indexed | 2024-03-09T02:51:23Z |
| format | Article |
| id | doaj.art-9f6f094a3a41479b98987ef3cf63d73e |
| institution | Directory Open Access Journal |
| issn | 1991-8690 2709-0256 |
| language | English |
| last_indexed | 2024-03-09T02:51:23Z |
| publishDate | 2019-04-01 |
| publisher | University of Thi-Qar |
| record_format | Article |
| series | مجلة علوم ذي قار |
| spelling | doaj.art-9f6f094a3a41479b98987ef3cf63d73e2023-12-05T09:58:25ZengUniversity of Thi-Qarمجلة علوم ذي قار1991-86902709-02562019-04-0163Prevalence of Toxoplasma gondii among immunocompromised patients (heamodialysis and cancer) in the province of Thi-Qar-IraqNoor Kadhim Matar AL-Rekaby0Bassad A.AL-Aboody 1Biology Department / College Science / Thi Qar universityBiology Department / College Science / Thi Qar universityThe current study was conducted in Thi-Qar province to investigate of Toxoplasma gondii prevalence among renal dialysis and cancer patients by using anti-Toxoplasmosis IgG and IgM by ELISA also the study determined of some factors that may affected the prevalence of infection, such as age, sex, marital status, place of residence and a number of chemical dosing that exposed to it cancer patient or the number of times the dialysis for renal dialysis patients. The results of the current study showed that the prevalence of toxoplasmosis in Thi-Qar province in both renal dialysis and cancer patients and control group were 28% and 36% and 24% respectively. recorded results of Enzyme Linked Immunosorbent Assay ELISA test results for a positive antibody IgG in both renal dialysis and cancer patients and control group 25% , 30% , 22% respectively. As for the IgM antibody study did not record any positive result in both categories of the study (dialysis and cancer) only control group was 2%. The result of IgG & IgM together in renal dialysis and cancer and control group 3%, 6%, 0% respectively. The study found that the increase in the number of times the dialysis increased incidence of infection prevalence it was 25.53% for patients who conducted the dialysis treatment more than six times and 16.66% for patients who have less than six times.For factor chemical dosing show high infection rates in patients who have been exposed to more than one dose of a chemical 37.63% As for those who were not exposed to any chemical dose was ratios have 14.29% .http://jsci.utq.edu.iq/index.php/main/article/view/41ToxoplasmosisHemodialysisimmunocompromised patientsLipid profileELISA Test |
| spellingShingle | Noor Kadhim Matar AL-Rekaby Bassad A.AL-Aboody Prevalence of Toxoplasma gondii among immunocompromised patients (heamodialysis and cancer) in the province of Thi-Qar-Iraq مجلة علوم ذي قار Toxoplasmosis Hemodialysis immunocompromised patients Lipid profile ELISA Test |
| title | Prevalence of Toxoplasma gondii among immunocompromised patients (heamodialysis and cancer) in the province of Thi-Qar-Iraq |
| title_full | Prevalence of Toxoplasma gondii among immunocompromised patients (heamodialysis and cancer) in the province of Thi-Qar-Iraq |
| title_fullStr | Prevalence of Toxoplasma gondii among immunocompromised patients (heamodialysis and cancer) in the province of Thi-Qar-Iraq |
| title_full_unstemmed | Prevalence of Toxoplasma gondii among immunocompromised patients (heamodialysis and cancer) in the province of Thi-Qar-Iraq |
| title_short | Prevalence of Toxoplasma gondii among immunocompromised patients (heamodialysis and cancer) in the province of Thi-Qar-Iraq |
| title_sort | prevalence of toxoplasma gondii among immunocompromised patients heamodialysis and cancer in the province of thi qar iraq |
| topic | Toxoplasmosis Hemodialysis immunocompromised patients Lipid profile ELISA Test |
| url | http://jsci.utq.edu.iq/index.php/main/article/view/41 |
| work_keys_str_mv | AT noorkadhimmataralrekaby prevalenceoftoxoplasmagondiiamongimmunocompromisedpatientsheamodialysisandcancerintheprovinceofthiqariraq AT bassadaalaboody prevalenceoftoxoplasmagondiiamongimmunocompromisedpatientsheamodialysisandcancerintheprovinceofthiqariraq |